single-chain , urokinase-type plasminogen activator ( pro-urokinase ) , isolated from the conditioned medium of a human renal adenocarcinoma cell line , was administered to six patients with evolving myocardial infarction of less than 5 hours ' duration and angiographically confirmed total occlusion of the infarct-related coronary artery .
C0042071
urokinase-type plasminogen activator
C0027051
myocardial infarction